Technology
Latest News
Advertisement
Advertisement
April 29, 2016.
Pharmaceutical Executive
Charting two years of collaborative progress in clinical trial data sharing.
April 27, 2016.
Pharmaceutical Executive
April 26, 2016.
April 26, 2016.
April 25, 2016.
April 19, 2016.
Pharmaceutical Executive
April 18, 2016.
April 13, 2016.
More than a year after approving its first biosimilar, FDA has authorized a second therapy in this category.
In many life situations, it’s difficult to be hopeful. But at SxSW Interactive last week, it was difficult to be pessimistic, writes Bill Drummy.
March 31, 2016.
March 31, 2016.
March 29, 2016.
Advertisement
Advertisement
Trending on PharmExec
1
ANI Pharmaceuticals to Acquire Egetis Therapeutics, Egetis Sells Priority Review Voucher for $190 Million
2
Why Leronlimab Isn’t Just Another Repurposed Drug: Q&A with Dr. Jay Lalezari
3
Pharmaceutical Executive Daily: Nxera Licenses EP4 Agonist to AbbVie
4
What Does a Positive Reading for Leronlimab Mean for How the Industry Thinks About Repurposing Old Biologics Into Oncology?
5